Is acute myeloid leukemia treatment possible without transplant?

Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.

What is the AML transplant success rate?

With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.

How long does acute myeloid leukemia (AML) treatment take?

Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.

How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?

AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib

What is acute myeloid leukemia (AML) remission treatment?

It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.

Is acute myeloid leukemia (AML) common in India?

Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.

Can children get AML?

Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.

What is acute lymphocytic leukemia (ALL)?

ALL is a fast-growing cancer of the bone marrow and blood that affects lymphoid precursor cells. It occurs in both children and adults and requires immediate, specialized treatment.

What are the early symptoms of Acute Lymphocytic Leukemia (ALL)

Common symptoms include fatigue, infections, bruising or bleeding, bone pain, and swollen lymph nodes. Prompt diagnosis is essential.

How is ALL diagnosed at BMT Next?

We use CBC, bone marrow biopsy, flow cytometry, cytogenetics (e.g., BCR-ABL1), MRD testing, and next-generation sequencing to confirm the diagnosis and subtype.

What is the success rate for pediatric Acute Lymphocytic Leukemia (ALL) at BMT Next?

In standard-risk pediatric ALL, our survival rates exceed 94%, aligning with top international benchmarks.

What is the role of bone marrow transplant in ALL?

BMT is offered to patients with high-risk features, poor response to induction therapy, relapsed disease, or specific cytogenetic abnormalities like Ph+ ALL.

Can adults with ALL also be treated at BMT Next?

Yes. We treat adult ALL using age-adapted protocols and offer reduced-intensity transplant regimens when needed.

What targeted therapies do you offer for relapsed or refractory Acute Lymphocytic Leukemia (ALL)?

We provide access to Blinatumomab (BiTE), Inotuzumab ozogamicin, and TKIs for Ph+ ALL. CAR-T therapy is coordinated with leading centers in India.

How does BMT Next support international patients from Mauritius or Africa?

We offer virtual consultations, visa and travel assistance, multilingual care coordination, and continuity of treatment between India and Mauritius.

Is CAR-T cell therapy available for Acute Lymphocytic Leukemia (ALL)at BMT Next?

Yes. We collaborate with accredited CAR-T therapy partners to treat CD19+ relapsed/refractory ALL cases.

How is MRD testing used to guide treatment?

MRD (Minimal Residual Disease) testing after induction and consolidation phases helps assess treatment effectiveness and guides the need for BMT.

What are the side effects of chemotherapy for Acute Lymphocytic Leukemia (ALL)?

Side effects include neutropenia, infections, nausea, hair loss, and fatigue. We manage toxicity through supportive care and growth factor use.

Do you provide fertility preservation for young ALL patients?

Yes. We offer fertility counseling and options like sperm banking and ovarian tissue preservation before intensive chemotherapy or transplant.

How long is treatment for acute lymphocytic leukemia?

Pediatric ALL treatment typically lasts 2–3 years. Adult protocols are shorter but may include transplant or advanced therapies.

What makes BMT Next different from other leukemia centers?

We provide MRD-guided treatment, access to immunotherapy and transplant, global referrals, and unmatched survival outcomes in India.

How can I book a second opinion at BMT Next?

You can request a virtual or in-person second opinion by sharing your reports through our patient portal or contacting our coordination team directly.

Why is BMT Next considered the best center for acute lymphocytic leukemia (ALL) treatment in Gurgaon (Gurugram)?

BMT Next in Gurgaon is equipped with advanced genomic testing, CAR-T therapy access, expert-led transplant services, and participation in international clinical trials. It offers personalized care for both pediatric and adult ALL patients, combining technology, experience, and outcomes that meet global standards.

What is multiple myeloma and how is it different from other blood cancers?

Multiple myeloma is considered a cancer of plasma cells, a type of white blood cell that helps fight infection. Unlike leukemia or lymphoma, it majorly affects the bone marrow and skeletal system.

What are the early signs of multiple myeloma?

Early signs include persistent bone pain, frequent infections, unexplained fatigue, anemia, kidney dysfunction, and high calcium levels.

How is multiple myeloma diagnosed at BMT Next?

We use a combination of blood tests (SPEP, IFE, FLC), bone marrow biopsy, PET-CT or MRI, and FISH cytogenetic studies to confirm diagnosis and risk stratify the disease.

What is the role of FISH cytogenetics in myeloma diagnosis?

FISH identifies genetic abnormalities like del(17p), t(4;14), or 1q gain, which help us predict prognosis and customize treatment.

Is bone marrow transplant mandatory for all myeloma patients?

No. Autologous stem cell transplant (ASCT) is recommended for eligible patients to prolong remission, but alternatives exist for transplant-ineligible individuals.

What is CAR-T therapy and is it available at BMT Next?

CAR-T therapy involves genetically modifying a patient’s own T-cells to fight myeloma. It is available through clinical access programs at BMT Next.

. What are the treatment options for relapsed or refractory myeloma?

Options include immunomodulators like Pomalidomide, monoclonal antibodies like Daratumumab, BiTE therapies, and CAR-T cells.

How does BMT Next monitor treatment response?

We use MRD (minimal residual disease) testing via flow cytometry or NGS to monitor the depth of remission after treatment.

Are there different types of multiple myeloma?

Yes, including smoldering myeloma (asymptomatic), active myeloma (requiring treatment), and relapsed/refractory myeloma.

What support services are offered at BMT Next for myeloma patients?

Patients receive nutritional counseling, pain management, physiotherapy, renal care, and emotional wellness support throughout treatment.

What makes BMT Next the best center for multiple myeloma treatment in India?

BMT Next offers the best multiple myeloma treatment in India through its expert-led centers in Gurgaon, Hisar, Faridabad, and Mauritius. Our strength lies in bone marrow transplant excellence, MRD-based treatment, next-level FISH cytogenetics, and access to CAR-T and BiTE therapy. Patients across North India and internationally choose BMT Next for high-quality, affordable, and personalized plasma cell cancer treatment.

How can patients from Mauritius access myeloma care at BMT Next?

Our international patient desk helps with appointment scheduling, visa support, travel coordination, and follow-up teleconsultation.

How often should follow-up occur after myeloma treatment?

Follow-up is typically every 3–6 months with blood tests, MRD monitoring, and imaging when needed.

What is lenalidomide maintenance and why is it important?

Lenalidomide is used after transplant or initial therapy to maintain remission and delay progression. It is a cornerstone of long-term management.

Are affordable treatment packages available for myeloma at BMT Next?

Yes. We offer cost-effective care across Hisar, Faridabad, and Gurgaon with insurance, CGHS, and EMI support.

What is the success rate of bone marrow transplant in India?

At leading centers like BMT Next, the success rate for bone marrow transplant ranges between 70% to 90%, depending on the disease type, patient condition, and transplant match. Conditions like thalassemia, aplastic anemia, and acute leukemia show high cure rates when treated early.

How much does a bone marrow transplant cost in India?

The cost varies between ₹8 to ₹25 lakhs, based on the type of transplant. Autologous BMTs are usually less expensive than allogeneic or haploidentical transplants. BMT Next offers transparent packages in Gurgaon, Faridabad, Hisar, and Mauritius with financial counseling support.

How long does a bone marrow transplant take?

The full procedure—including pre-evaluation, transplant, and initial recovery—typically takes 4 to 6 weeks. Post-discharge monitoring continues for 6 to 12 months depending on the patient’s immune recovery.

Who can be a donor for bone marrow transplant?

Donors may be siblings, matched unrelated individuals, or half-matched (haploidentical) family members. At BMT Next, we conduct HLA typing and also work with global donor registries if a family match isn’t available

Is bone marrow transplant painful?

The transplant itself is not painful. It’s a stem cell infusion given through a vein, very similar to a blood transfusion. Pre-transplant chemotherapy may cause side effects, which are managed by our transplant care team.

Which diseases are treated with bone marrow transplant?

We treat leukemia, lymphoma, multiple myeloma, aplastic anemia, thalassemia, sickle cell anemia, MDS, and rare immunodeficiency syndromes. BMT Next specializes in both adult and pediatric BMTs across all these conditions.

Can international patients get bone marrow transplant in India?

Yes. Through our Mauritius center, international patients from Africa, the Middle East, and Indian Ocean islands can access India’s best BMT care with visa assistance, translator support, and telemedicine follow-up.

What are the risks of bone marrow transplant?

Like any major medical procedure, BMT carries risks such as infection, graft-versus-host disease (GVHD), and delayed engraftment. However, at BMT Next, we use strict infection control, ICU monitoring, and early GVHD management to minimize complications.

Why is BMT Next considered among the best bone marrow transplant centers in India?

With over 3,000+ transplants performed, MRD-guided therapy, internationally trained specialists, and a strong presence in Gurgaon, Faridabad, Hisar, and Mauritius, BMT Next combines experience with accessibility and affordability.

How soon should I consult for a bone marrow transplant?

Early consultation is critical—especially for high-risk leukemia, aplastic anemia, or relapsed cancers. Delays can affect survival. Contact BMT Next today to schedule a transplant evaluation at your nearest center.

Best Bone Marrow Transplant Center In hisar

If you or your loved one is searching for the best bone marrow transplant Hospital in Hisar, you’re in the right place. At BMT Next, we bring world-class transplant care to Hisar, combining clinical excellence with affordability. Our state-of-the-art BMT unit in Hisar is equipped to handle complex transplants with a high success rate, including autologous and allogeneic procedures.

Patients from across India trust us because we offer personalized bone marrow transplant solutions in Hisar, Gurgaon, Faridabad, and Mauritius for conditions like leukemia, lymphoma, aplastic anemia, and more. With expert doctors, cutting-edge infrastructure, and a compassionate care team, BMT Next is recognized as the most trusted bone marrow transplant hospital in Hisar.

We don’t just treat diseases—we give patients a new chance at life. Whether you’re exploring transplant options or seeking a second opinion, our team in Hisar is here to guide you every step of the way.

What Is Bone Marrow Transplant & Why BMT in Hisar?

A bone marrow transplant (BMT) is a life-saving medical procedure used to replace damaged or diseased bone marrow with healthy stem cells. In Hisar, BMT Next has made this advanced therapy accessible to patients suffering from blood cancers like leukemia and lymphoma, as well as bone marrow failure syndromes like aplastic anemia and thalassemia.

At our best bone marrow transplant centers in Hisar,Gurgaon, Faridabad and Mauritius we offer both autologous (self-donor) and allogeneic (donor-based) transplants, using globally accepted protocols tailored to Indian patients. This allows us to achieve high success rates while minimizing complications.

Hisar is fast emerging as a hub for hematology and transplant care, thanks to the presence of top-tier specialists, affordability, and strong follow-up services. With our expert BMT team also operating in Gurgaon, Faridabad, and Mauritius, patients in Hisar gain the benefit of multi-location support, second opinions, and referrals when needed—without leaving their city.

When you choose BMT Next in Hisar, you’re not just choosing treatment; you’re choosing a trusted, world-class transplant ecosystem rooted in your local community.

Types of Bone Marrow Transplant We Offer in Hisar

BMT Next is proud to offer a full spectrum of best bone marrow transplant procedures at our advanced facility in Hisar. Each transplant is performed under the supervision of experienced hemato-oncologists and transplant specialists, with strict infection control and 24×7 post-transplant monitoring. Whether you’re looking for an autologous transplant for multiple myeloma or a matched sibling donor transplant for leukemia, our Hisar unit delivers world-class results—right here in your city.

Autologous Bone Marrow Transplant in Hisar (Self Stem Cells)

In this type of bone marrow transplant, healthy stem cells are harvested from the patient’s own body before undergoing high-dose chemotherapy or radiation. The cells are then reinfused to help regenerate healthy bone marrow. This method is primarily used for multiple myeloma, relapsed Hodgkin lymphoma, and certain solid tumors.
At BMT Next Hisar, we use advanced cryopreservation methods to ensure stem cell viability, reduce side effects, and accelerate recovery.

Allogeneic Bone Marrow Transplant in Hisar (Donor Stem Cells)

An allogeneic transplant involves replacing a patient’s diseased marrow with stem cells from a healthy donor—usually a sibling or unrelated matched donor. This is the most common approach for treating acute leukemia, aplastic anemia, MDS, thalassemia major, and bone marrow failure syndromes.
Our Bone marrow transplant center in Hisar performs precise HLA typing and donor selection to ensure successful engraftment and reduce graft-versus-host disease (GVHD). We also offer matched unrelated donor (MUD) BMT in Hisar in select cases through international registry coordination.

Haploidentical Bone Marrow Transplant in Hisar (Half-Matched Donor)

When a fully matched donor is not available, a haploidentical or half-matched transplant using a parent, child, or sibling can be life-saving. Our expert team at BMT Next Hisar has successfully performed multiple haplo transplants with excellent outcomes using post-transplant cyclophosphamide protocols to prevent rejection.
This option has expanded transplant accessibility for families in and around Hisar.

Umbilical Cord Blood Transplant

Though rare and used mostly in pediatric blood disorders, cord blood transplants are sometimes needed when no matched donor is available.

Each type of transplant is there with its own risks, benefits, and suitability criteria. Our multidisciplinary transplant board evaluates each case to ensure the safest and most effective treatment is offered at our best bone marrow transplant hospital in Hisar, Gurgaon, Haryana.

Diseases Treated with Bone Marrow Transplant in Hisar

At BMT Next Hisar, we specialize in treating a wide range of life-threatening and chronic blood disorders through best bone marrow transplant. With a high-precision diagnostic approach and evidence-based transplant protocols, our goal is to provide curative treatment to both adult and pediatric patients suffering from severe hematological conditions.

eukemia Treatment with Top Bone Marrow Transplant Hospital in Hisar

Leukemia, a cancer of the blood and bone marrow, is one of the most common reasons for bone marrow transplants. BMT Next Hisar provides cutting-edge treatment options for both acute leukemia (AML, ALL) and chronic leukemia (CML, CLL) through autologous and allogeneic bone marrow transplants. For acute myeloid leukemia (AML), patients often undergo chemotherapy followed by an allogeneic transplant if remission is not achieved. In acute lymphoblastic leukemia (ALL), a stem cell transplant may be considered after induction therapy to ensure long-term remission.

BMT Next offers specialized care with high success rates, especially for high-risk leukemia patients in Hisar. Our team uses HLA matching technology to ensure precise donor matches, providing the best possible chance for a successful bone marrow transplant. Whether it’s a matched sibling donor or an unrelated donor, our advanced protocols ensure optimal outcomes for leukemia patients in Hisar and surrounding areas.

Lymphoma Treatment with Bone Marrow Transplant in Hisar

Lymphoma, including both Hodgkin lymphoma and non-Hodgkin lymphoma, can be effectively treated through best bone marrow transplant (BMT) in Hisar. At BMT Next, we specialize in autologous stem cell transplants for lymphoma patients who are refractory or relapse after chemotherapy. In some cases, allogeneic bone marrow transplants are used, especially for high-risk lymphoma patients or those with aggressive forms.

An autologous bone marrow transplant involves harvesting the patient’s own healthy stem cells, which are later infused after high-dose chemotherapy to destroy cancer cells. This treatment is proven to significantly improve survival rates for patients with non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma in Hisar. Our Hisar center ensures cutting-edge technology and personalized care to reduce risks like graft-versus-host disease (GVHD) in allogeneic transplants, offering a highly effective approach for lymphoma patients.

Multiple Myeloma Treatment with Top Bone Marrow Transplant Hospital in Hisar

For multiple myeloma, a cancer of the plasma cells, bone marrow transplant remains one of the most effective treatments. At BMT Next Hisar, we offer autologous stem cell transplants, which have proven to improve long-term survival for patients with multiple myeloma. In an autologous transplant, the patient’s own stem cells are taken and reintroduced after chemotherapy to rejuvenate the bone marrow.

This transplant option is recommended for patients with relapsed multiple myeloma or high-risk disease. Patients in Hisar benefit from our expert team who specializes in high-dose chemotherapy followed by stem cell infusion. We utilize the latest cryopreservation techniques to preserve stem cells and ensure optimal recovery post-transplant. With high success rates and personalized treatment plans, BMT Next Hisar is a trusted name for multiple myeloma bone marrow transplants in Haryana.

Aplastic Anemia Treatment with Bone Marrow Transplant in Hisar

Aplastic anemia, a serious condition where the bone marrow fails to produce enough blood cells, can be treated with bone marrow transplant (BMT) to restore healthy cell production. BMT Next Hisar offers matched sibling donor transplants for young patients suffering from severe aplastic anemia, which is considered a curative treatment.

For patients without a matched sibling, haploidentical transplants, using a half-matched family donor, are also available. Our BMT specialists in Hisar, Haryana provides detailed counseling on donor selection and the risks of the transplant process, ensuring the best possible care. After transplant, patients are carefully monitored for complications like graft rejection and infection, with a focus on post-transplant recovery.

BMT Next Hisar has a high success rate for aplastic anemia transplants, especially when the procedure is performed early, offering patients hope for a full recovery and long-term survival.

Thalassemia Treatment with Best Bone Marrow Transplant Hospital in Hisar

For children and adults suffering from thalassemia, a genetic blood disorder, bone marrow transplant (BMT) is the only curative treatment. BMT Next Hisar provides early autologous and allogeneic transplants to patients with thalassemia major, significantly improving their quality of life by eliminating the need for lifelong blood transfusions.

A bone marrow transplant can be a life-changing procedure for thalassemia patients, especially when done early, before the development of complications such as organ damage. At our Hisar facility, we offer pediatric thalassemia BMT services, with a focus on using HLA-matched sibling donors or haploidentical donors for the procedure. The results are remarkable, with patients experiencing long-term remission and improved blood counts post-transplant.

Sickle Cell Disease Treatment with Bone Marrow Transplant in Hisar

Sickle cell disease (SCD) is a genetic blood disorder that causes pain, organ damage, and anemia. For patients with severe forms of Sickle Cell Disease (SCD), a bone marrow transplant (BMT) is the only potential cure. At BMT Next Hisar, we offer stem cell transplants for patients with sickle cell anemia, focusing on matched sibling donors or haploidentical donors when necessary.

The bone marrow transplant process for sickle cell disease involves changing the patient’s defective bone marrow with healthy stem cells from a donor. This curative treatment helps to restore normal hemoglobin production and alleviate symptoms. Patients undergoing transplant at our Hisar center experience long-term relief from painful crises, reduced hospitalizations, and a better quality of life.

BMT Next Hisar ensures that sickle cell patients receive comprehensive care, with expert doctors and a dedicated post-transplant recovery plan that maximizes the chances of a successful outcome.

Myelodysplastic Syndrome (MDS) Treatment with Bone Marrow Transplant in Hisar

Myelodysplastic syndrome (MDS) is a condition that occurs when the bone marrow fails to produce enough healthy blood cells, often leading to anemia, bleeding, or infection. BMT Next Hisar offers allogeneic bone marrow transplants as a life-saving treatment for MDS patients, particularly those with high-risk MDS or secondary MDS.

The bone marrow transplant procedure for Myelodysplastic Syndrome (MDS) involves replacing the defective bone marrow with healthy donor stem cells. HLA-matching is crucial in this process to prevent complications such as graft-versus-host disease (GVHD). At Hisar, we use advanced genetic testing to select the best match for the patient, ensuring the highest probability of a successful transplant.

For patients with advanced Myelodysplastic Syndrome (MDS), an early transplant can significantly improve survival rates, offering hope for long-term remission. BMT Next Hisar is equipped with specialized care for MDS patients, offering cutting-edge bone marrow transplant protocols and post-transplant monitoring.

Bone Marrow Failure Syndromes Treatment

Bone marrow failure syndromes like severe aplastic anemia or Fanconi anemia end up in the inability of the bone marrow to produce enough blood cells. For patients diagnosed with these conditions, bone marrow transplant (BMT) is often the only curative option. At BMT Next Hisar, we provide allogeneic transplants using matched sibling donors or haploidentical donors to restore normal bone marrow function.

Bone marrow failure patients require immediate care to avoid complications like infection and bleeding. Our Hisar facility is equipped with a team of experts in stem cell biology and transplant procedures to ensure the best outcomes. We offer comprehensive pre-transplant evaluation, ensuring that each patient receives the right type of transplant for their condition.

At BMT Next Hisar, our priority is to provide personalized care and achieve the highest success rates for bone marrow failure syndrome patients through timely intervention and advanced transplant protocols.

Bone Marrow Failure Syndromes Treatment with Bone Marrow Transplant Hospital

Bone marrow failure syndromes like Fanconi anemia, Shwachman-Diamond syndrome, and dyskeratosis congenita can be treated with bone marrow transplant (BMT). These conditions occur when the bone marrow fails to produce adequate blood cells, leading to severe anemia, infections, and bleeding. BMT Next Hisar provides autologous and allogeneic transplants to patients suffering from these syndromes, offering a chance for long-term survival and improved quality of life.

For conditions like Fanconi anemia, where patients often face challenges in finding a matched donor, haploidentical transplants are an option. At our Hisar facility, we provide personalized care, including genetic testing and post-transplant care, to minimize risks and improve outcomes. Best Bone marrow transplant offers hope for patients suffering from these rare but serious conditions, allowing them to live free from the debilitating effects of bone marrow failure.

Step 1: Initial Consultation & Diagnosis

The first step is a comprehensive consultation with our experienced hematologists. They will assess your medical history, perform necessary tests, and confirm whether a bone marrow transplant is the right treatment for your condition. In Hisar, we specialize in treating a variety of blood disorders such as leukemia, lymphoma, and aplastic anemia.

Step 2: Pre-Transplant Evaluation

Before the transplant, a thorough pre-transplant evaluation is carried out. This includes blood tests, imaging studies, and organ function assessments. For allogeneic transplants, a donor search will begin, and HLA matching is done to find the most suitable donor.

Step 3: Conditioning Treatment

Conditioning involves high-dose chemotherapy and/or radiation therapy framed to end the diseased bone marrow. This prepares the body for the new stem cells and helps prevent rejection. The Bone Marrow Transplant team in Hisar carefully monitors the patient during this phase to manage side effects.

Step 5: Post-Transplant Care & Monitoring

After the transplant, patients are closely monitored in our post-transplant care unit. Our specialists track recovery, manage any side effects (like graft-versus-host disease in allogeneic transplants), and ensure the new stem cells are engrafting properly. Long-term care plans are established to help the patient return to normal life.

Our Hisar bone marrow transplant hospital is equipped with advanced infection control protocols, nutritional care, and psychological support to help every patient heal successfully post-transplant.

Step 4: Stem Cell Infusion

Once the patient has undergone conditioning treatment, healthy stem cells from the patient (in autologous BMT) or a donor (in allogeneic BMT) are infused into the bloodstream. This procedure takes only a few hours and is relatively simple, although it requires monitoring for any complications.

Bone Marrow Transplant Hospital Cost in Hisar

The cost of bone marrow transplant (BMT) can vary depending on several factors, including the type of transplant (autologous or allogeneic), the patient’s condition, and the complexity of the procedure. At BMT Next Hisar, we are committed to offering affordable and transparent pricing for bone marrow transplant procedures, without compromising on quality care.

Autologous Bone Marrow Transplant Cost

An autologous bone marrow transplant involves using the patient’s own stem cells, which can lower costs compared to an allogeneic transplant. The cost of autologous BMT in Hisar typically ranges from ₹12,00,000 to ₹15,00,000, depending on the pre-transplant treatments, hospitalization duration, and post-transplant care.

Allogeneic Bone Marrow Transplant Cost

An allogeneic transplant (where stem cells come from a donor) involves additional expenses, including the cost of finding a suitable matched donor and the associated immunosuppressive therapy to prevent graft-versus-host disease (GVHD). The typical allogeneic transplant cost at BMT Next Hisar ranges from ₹20,00,000 to ₹30,00,000, depending on the type of donor (related or unrelated) and the patient’s specific medical needs.

Factors Affecting BMT Cost in Hisar

The bone marrow transplant cost might be influenced by:

Type of transplant (autologous vs. allogeneic)
Donor matching and HLA typing
Pre-transplant chemotherapy and conditioning
Hospital stay and supportive care
Post-transplant monitoring and medication

Cost Comparison: BMT in Hisar vs Other Locations

When compared to transplant centers in Gurgaon or Mumbai, the cost of bone marrow transplant in Hisar is typically more affordable, making it an excellent option for patients seeking world-class care at a fraction of the cost.

Donor Eligibility and Matching for Bone Marrow Transplant in Hisar

Meet Our Bone Marrow Transplant Experts in hisar

Meet Kumar – MD, DM (Clinical Hematology), an expert in advanced allogeneic and haploidentical transplants. With over 1,000 successful Bone Marrow Transplants to his credit, he is known for handling high-risk AML, MDS, and rare genetic disorders with precision and compassion.

Neeraj Teotia – Dr. Teotia Specializes in pediatric stem cell transplants and immunodeficiency syndromes. He has been instrumental in establishing successful protocols for thalassemia major and aplastic anemia in children, with international training in pediatric Bone Marrow Transplant techniques.

Umesh Yadav – Renowned for his work in relapsed/refractory leukemia, multiple myeloma, and integration of immunotherapy in transplantation. He brings deep insight into personalized transplant planning, CAR-T cell research, and managing post-transplant complications.

Dr. Sumit Joshi – Senior Supervisor, Hemato-Oncology and BMT. With over 14 years of experience and more than 500 Bone Marrow Transplants supervised (including autologous, allogeneic, and haploidentical), he is certified in infection control, ventilator management, PICC line care, and post-transplant complication management. He has worked with top hospitals across India and Mauritius.

Step-by-Step Transplant Journey at BMT Next

1. Evaluation & Counseling

Disease staging
Organ function tests
Psychological readiness

2. Donor Search & Clearance

Sibling matching
Haploidentical donor evaluation
International registry search (if needed)

3. Pre-Transplant Conditioning

Chemotherapy and/or radiation
Infection prophylaxis

4. Stem Cell Infusion

IV infusion in a sterile setting
Daily monitoring of blood counts and vital signs

5. Engraftment & Recovery

White cell recovery within 14–21 days (on average)
Red cell and platelet support

6. Long-Term Follow-up

Monthly review for 1 year
GVHD surveillance
Immunization & fertility preservation support